Financial Performance

iGrow News Financial Performance
ADAMA reports Q3 2025 sales of $933M and 50% EBITDA growth, driven by higher volumes, improved mix, and “Fight Forward” initiatives.

ADAMA Reports Improved Financials in Q4 2025 Results

ADAMA achieved a 25% increase in adjusted EBITDA to $587 million for full year 2025, with EBITDA margin improving from 11.3% to 14.5%.

Read More
ADM reports Q3 2025 earnings of $108M, adjusted EPS $0.92, driven by strong Nutrition gains; revises FY EPS to $3.25–$3.50.

ADM Partners with American Farmland Trust for Farm Resilience

ADM (NYSE: ADM) has announced a significant partnership with the American Farmland Trust (AFT) to bolster agricultural resilience across the U.S. Midwest and Plains.

Read More
Bunge Global posts Q3 2025 adjusted EPS of $2.27, driven by strong Oilseeds and Softseed Refining; reaffirms $7.30–$7.60 outlook.

Bunge Global SA Announces Strategic Growth Targets and $3Bn Share Repurchase Plan

Bunge has updated its mid-cycle EPS baseline to approximately $13, with a projected increase to at least $15 by 2030.

Read More
Intrepid Potash Reports Full Year 2025 Financial Results

Intrepid Potash Reports Full Year 2025 Financial Results

Intrepid Potash announces Kevin S. Crutchfield as Chief Executive Officer and Board Director, effective immediately.

Read More
FMC Corporation reported Q3 2025 revenue of $542 million (–49% YoY) due to India charges; adjusted EBITDA rose 17% to $236 million.

FMC’s Rimisoxafen Receives Historic Dual Mode of Action Classification from HRAC

FMC Corporation announced that HRAC classified rimisoxafen as a dual mode of action herbicide under Groups 12 and 32.

Read More
Farmland Partners raises 2025 AFFO outlook after Q3 results; AFFO up 106%, debt reduced, and liquidity strong at $172.5M.

Farmland Partners Inc. Reports 2025 Financial Results and Raises Dividend

Farmland Partners reported improved results for Q2 2025, driven primarily by gains from farmland sales and ongoing share repurchase activity.

Read More
Nutrien reports Q3 2025 net earnings of $0.5B and adjusted EBITDA of $1.4B; reviews Phosphate business and sells Profertil stake.

Nutrien Reports Q4 2025 Results, Portfolio Actions, and 2026 Guidance

Nutrien reported fourth quarter 2025 net earnings of $0.58 billion ($1.18 per diluted share) and adjusted EBITDA of $1.28 billion.

Read More
Valmont Industries Q3 2025 sales up 2.5% to $1.05B; EPS rises 21% to $4.98; raises full-year outlook on strong Utility demand and backlog.

Valmont Industries Reports Q4 and Full-Year 2025 Results, Introduces 2026 Outlook

Valmont® Industries, Inc. today reported financial results for the second quarter ended June 28, 2025 and raises full-year outlook.

Read More
CHS earns $597.9M on $35.5B revenue; Energy dips on tighter margins, Ag stays resilient, and $120M returned to members.

CHS and Sunrise Cooperative Restructure Partnership to Strengthen Crop Nutrients Supply Chain

CHS Inc. reported first quarter fiscal year 2026 results for the period ended November 30, 2025, posting net income of $260.5 million on revenues of $8.9 billion.

Read More
AGCO reports Q3 2025 sales of $2.5B, led by EME growth. Launches $1B share repurchase; full-year EPS guided to ~$5.00.

AGCO Reports Q4 and FY 2025 Results Amid Mixed Global Market Conditions

Key Takeaways: AGCO reported fourth-quarter 2025 net sales of $2.9 billion, up 1.1% year over year. Reported net income was $1.30 per share in Q4 2025, compared with a net […]

Read More